Evidence map›Paper›PMID 24531392›Full record

ArticleInternational journal of nanomedicine2014

Curcumin and 5-fluorouracil-loaded, folate- and transferrin-decorated polymeric magnetic nanoformulation: a synergistic cancer therapeutic approach, accelerated by magnetic hyperthermia.

Sivakumar Balasubramanian, Aswathy Ravindran Girija, Yutaka Nagaoka, Seiki Iwai, Masashi Suzuki, Venugopal Kizhikkilot, Yasuhiko Yoshida, Toru Maekawa, Sakthikumar Dasappan Nair

Abstract read
In one paragraph

Article in International journal of nanomedicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Advances in magnetic induction hyperthermia.Frontiers in bioengineering and biotechnology · 2024
    Review
  7. Review
  8. Article
  9. Pharmacokinetics and tumor delivery of nanoparticles.Journal of drug delivery science and technology · 2023
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Magnetic Nanoparticles in Cancer Therapy and Diagnosis.Advanced healthcare materials · 2020
    Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sivakumar BalasubramanianBio Nano Electronics Research Center, Graduate School of Interdisciplinary New Science, Toyo University, Kawagoe, Japan.
Aswathy Ravindran GirijaBio Nano Electronics Research Center, Graduate School of Interdisciplinary New Science, Toyo University, Kawagoe, Japan.
Yutaka NagaokaBio Nano Electronics Research Center, Graduate School of Interdisciplinary New Science, Toyo University, Kawagoe, Japan.
Seiki IwaiBio Nano Electronics Research Center, Graduate School of Interdisciplinary New Science, Toyo University, Kawagoe, Japan.
Masashi SuzukiBio Nano Electronics Research Center, Graduate School of Interdisciplinary New Science, Toyo University, Kawagoe, Japan.
Venugopal KizhikkilotDepartment of Respiratory Medicine, Sooriya Hospital, Chennai, India.
Yasuhiko YoshidaBio Nano Electronics Research Center, Graduate School of Interdisciplinary New Science, Toyo University, Kawagoe, Japan.
Toru MaekawaBio Nano Electronics Research Center, Graduate School of Interdisciplinary New Science, Toyo University, Kawagoe, Japan.
Sakthikumar Dasappan NairBio Nano Electronics Research Center, Graduate School of Interdisciplinary New Science, Toyo University, Kawagoe, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The efficient targeting and therapeutic efficacy of a combination of drugs (curcumin and 5-Fluorouracil [5FU]) and magnetic nanoparticles encapsulated poly(D,L-lactic-co-glycolic acid) nanoparticles, functionalized with two cancer-specific ligands are discussed in our work. This multifunctional, highly specific nanoconjugate resulted in the superior uptake of nanoparticles by cancer cells. Upon magnetic hyperthermia, we could harness the advantages of incorporating magnetic nanoparticles that synergistically acted with the drugs to destroy cancer cells within a very short period of time. The remarkable multimodal efficacy attained by this therapeutic nanoformulation offers the potential for targeting, imaging, and treatment of cancer within a short period of time (120 minutes) by initiating early and late apoptosis.

Indexed as

AnimalsAntineoplastic AgentsApoptosisCell LineCombined Modality TherapyCurcuminDrug CarriersFluorouracilFolic AcidHumansHyperthermia, InducedLactic AcidMagnetite NanoparticlesMCF-7 CellsMiceNanoconjugatesAntineoplastic AgentsCurcuminDrug CarriersFluorouracilFolic AcidLactic AcidMagnetite NanoparticlesNanoconjugatesPolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerTransferrin5FUcurcuminfolatemagnetic hyperthermiananotechnologyPLGA nanoparticletransferrin

Identifiers

PMID24531392
PMCPMC3891567

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.